Congenital adrenal hyperplasia — a group of autosomal recessive disorders of adrenal steroidogenesis affecting approximately 1 in 15,000 live births in the classic form, caused by enzyme deficiencies in the cortisol biosynthetic pathway resulting in cortisol insufficiency, compensatory ACTH hypersecretion driving adrenal hyperplasia, and shunting of steroid precursors into adrenal androgen pathways — most commonly caused by CYP21A2 mutations encoding 21-hydroxylase (21-OHD, accounting for approximately 90–95% of all CAH cases, with the classic salt-wasting form in 75% of 21-OHD — severe mutations causing complete enzyme absence, presenting in the neonatal period with adrenal crisis characterized by hyponatremia, hyperkalemia, vascular collapse, and virilization of female newborns, and the classic simple-virilizing form in 25% of 21-OHD — partial enzyme activity preserving mineralocorticoid sufficiency but causing virilization), with less common causes including CYP11B1 mutations encoding 11-beta-hydroxylase (second most common at 5–8%, accumulation of 11-deoxycortisol causing hypertension from mineralocorticoid excess rather than salt-wasting), CYP17A1 mutations encoding 17-alpha-hydroxylase (rare, combined 17-alpha-hydroxylase and 17,20-lyase deficiency causing sex hormone deficiency and hypertension), and rare forms including CYP11A1 (cholesterol side-chain cleavage), HSD3B2 (3-beta-hydroxysteroid dehydrogenase), StAR (steroidogenic acute regulatory protein deficiency causing lipoid CAH), and POR (P450 oxidoreductase) deficiencies — universally identified on newborn screening by elevated 17-hydroxyprogesterone (17-OHP) on dried bloodspot specimens, with confirmatory serum 17-OHP, androstenedione, testosterone, and electrolytes, and immediately treated with hydrocortisone for glucocorticoid replacement (10–15 mg/m²/day divided three times daily in infants, adjusted by 17-OHP, androstenedione, and growth velocity in children) and fludrocortisone for mineralocorticoid replacement in the salt-wasting form (0.05–0.2 mg/day with sodium supplementation in infancy), with the life-threatening adrenal crisis risk requiring every patient, family member, and treating physician to know the sick-day rule: tripling the hydrocortisone dose during febrile illness, vomiting, or any physiological stress, and administering intramuscular hydrocortisone (Solu-Cortef 25 mg IM for children <3 years, 50 mg for children 3–12 years, 100 mg for adolescents and adults) for any inability to take oral medication, impending or actual vomiting, altered consciousness, or emergency surgical procedure.
Congenital adrenal hyperplasia technology platforms — encompassing the newborn metabolic screening laboratory information systems where dried bloodspot 17-OHP measurements identify neonates with CAH within days of birth, the pediatric endocrinology electronic health record and scheduling platforms where specialist physicians manage hydrocortisone and fludrocortisone dose adjustment guided by serial hormonal monitoring, the adrenal crisis emergency alert systems and sick-day protocol distribution platforms ensuring families and emergency physicians have immediate access to stress dosing guidelines, the hormonal monitoring laboratory platforms tracking serial 17-OHP, androstenedione, testosterone, ACTH, and urine pregnanetriol measurements that guide dose adjustment without either undertreating (elevated androgens causing virilization and advanced bone age) or overtreating (excess glucocorticoid causing growth suppression and iatrogenic Cushing syndrome), the multi-disciplinary coordination platforms connecting endocrinology with urology and gynecology for genital reconstructive surgery coordination in virilized females, the bone age and growth monitoring systems tracking auxological consequences of androgen excess and glucocorticoid overtreatment, and the long-term fertility surveillance platforms for adult patients managing gonadotropin-independent precocious puberty history, polycystic ovarian morphology, or adrenal rest tumors in the testis — must maintain the availability and performance standards required by the adrenal crisis prevention imperative, the serial hormonal monitoring frequency, the genital reconstructive surgery coordination complexity, and the sick-day rule compliance infrastructure that define modern CAH management. This guide explains why congenital adrenal hyperplasia tech platforms need dedicated monitoring, what components to monitor, and how to build a monitoring strategy matched to the adrenal crisis emergency prevention, serial 17-OHP monitoring precision, multi-disciplinary care coordination, and stress dosing protocol distribution requirements of modern management.
Why Congenital Adrenal Hyperplasia Tech Platforms Require Specialized Monitoring Attention
Congenital adrenal hyperplasia management is defined by several uniquely life-threatening endocrinology management challenges: the adrenal crisis emergency imperative — in the classic salt-wasting form, a fever, vomiting, diarrhea, or surgical procedure can precipitate a life-threatening adrenal crisis within hours, making the sick-day protocol and emergency intramuscular hydrocortisone access the most critical patient safety systems in CAH care; the hormonal monitoring precision requirement — the therapeutic window for hydrocortisone dosing in CAH is narrow, because underdosing allows ACTH excess to drive androgen overproduction causing clitoromegaly or penile growth, accelerated linear growth with advanced bone age, and early epiphyseal fusion causing short final adult height, while overdosing causes growth suppression, weight gain, striae, hypertension, and iatrogenic Cushing syndrome — serial 17-OHP, androstenedione, and growth velocity measurements at every visit are the primary titration tools; the multi-disciplinary coordination complexity — virilized females with classic CAH require joint management by endocrinology, pediatric urology or gynecology for genital reconstructive surgery timing and counseling, reproductive endocrinology for fertility preservation, and psychology for gender identity and body image support; and the long-term adrenal rest tumor surveillance — bilateral testicular adrenal rest tumors (TART) affect 25–94% of adult males with classic CAH, causing infertility if not detected and managed, requiring annual testicular ultrasound in post-pubertal males.
Adrenal crisis emergency alert systems must be available to patients, families, and emergency physicians at all times. The sick-day protocol — written instructions for stress dosing with oral hydrocortisone and the emergency intramuscular hydrocortisone kit — must be accessible to families via portal, to emergency physicians via clinical decision support, and to school nurses via school accommodation documents, 24 hours a day. Monitor adrenal crisis emergency alert and protocol platforms at 1-minute intervals, 24/7.
Newborn metabolic screening LIS platforms are the time-critical entry point for CAH diagnosis. Elevated 17-OHP on dried bloodspot triggers immediate notification, confirmatory testing, and salt-supplemented emergency treatment for neonates with the salt-wasting form who may present in adrenal crisis within the first two weeks of life. Monitor newborn screening platforms at 1-minute intervals during laboratory operational hours.
Serial hormonal monitoring platforms guide the narrow therapeutic window. 17-OHP, androstenedione, testosterone, and urine pregnanetriol measurements at every endocrinology visit are the biochemical tools that prevent both virilization and iatrogenic Cushing. Monitor laboratory results and hormonal monitoring scheduling platforms at 1-minute intervals during clinical hours.
Multi-disciplinary endocrinology and surgery coordination portals manage genital reconstructive surgery planning. Timing, counseling, psychological support, and surgical coordination for virilized females require platform availability across specialties. Monitor multi-disciplinary coordination portals at 1-minute intervals during clinic hours.
Bone age and growth monitoring systems track the clinical consequence of hormonal control. Growth velocity deceleration and advanced bone age are the clinical manifestation of androgenic overproduction; growth failure is the manifestation of glucocorticoid excess. Monitor growth surveillance platforms at 1-minute intervals during clinical hours.
What to Monitor on a Congenital Adrenal Hyperplasia Tech Platform
Newborn Metabolic Screening LIS and Emergency Neonatal Notification
Monitor 17-OHP dried bloodspot measurement records (immunoassay batch completion, gestational age-adjusted reference range application — premature infants have physiologically elevated 17-OHP requiring gestational age correction; day of life correction for specimens collected within 24 hours of birth; birth weight correction; sex-stratified cutoffs), critical value notification records (17-OHP above the action level triggering immediate telephone notification to birth hospital or primary care provider — notification timestamp, recipient name, recommended action: same-day confirmatory serum 17-OHP, electrolytes, and bedside glucose with endocrinology consultation), confirmatory serum testing records (serum 17-OHP, cortisol, ACTH, 11-deoxycortisol, androstenedione, testosterone, DHEA-S, aldosterone, plasma renin activity, electrolytes, glucose), and neonatal emergency treatment records (empirical hydrocortisone and fludrocortisone initiation with sodium supplementation in infants with critical 17-OHP elevation and hyponatremia before confirmatory results return) at 1-minute intervals during laboratory operational hours. Alert immediately — a newborn screening LIS failure during the overnight processing of a state's daily bloodspot batch delays the 17-OHP critical value notification for a five-day-old male with classic salt-wasting CAH whose sodium has been falling for 24 hours and who will present to the emergency department in adrenal crisis within 12 hours if emergency hydrocortisone initiation is not triggered today.
Adrenal Crisis Emergency Alert and Sick-Day Protocol Platforms
Monitor sick-day rule documentation records (written sick-day protocol in patient portal: "For fever above 38.5°C, vomiting, or any illness — triple the daily hydrocortisone dose and give every 8 hours; for inability to take oral medication or repeated vomiting — administer emergency hydrocortisone injection kit and call 911"), emergency hydrocortisone kit prescription records (Solu-Cortef Act-O-Vial 100 mg powder kit — prescription validity, pharmacy dispensing confirmation, kit expiry date tracking, replacement prescription triggers), emergency department clinical decision support records (physician-accessible CAH emergency protocol: "Suspect adrenal crisis in known CAH patient with vomiting, hypotension, hyponatremia, hyperkalemia, or altered consciousness — hydrocortisone 50–100 mg/m² IV stat, normal saline 20 mL/kg bolus, glucose monitoring, endocrinology consultation"), school nurse accommodation records (written individual health plan — IHP — with sick-day dosing schedule and emergency injection instructions for school setting), and intercurrent illness stress dosing adherence records (family-reported illness stress dosing events documented at follow-up visits, adherence pattern tracking) at 1-minute intervals, 24/7. Alert immediately — adrenal crisis emergency protocol platform failures at 11:30 PM when a family accesses their child's patient portal to confirm the stress dosing instructions for a 9-year-old with classic salt-wasting CAH who has been vomiting for 4 hours and has a fever of 39.2°C — and finds the portal unavailable — convert a manageable sick-day management situation into an emergency department visit that could have been avoided with timely home intramuscular hydrocortisone administration following the sick-day protocol.
Serial Hormonal Monitoring and Dose Adjustment Scheduling
Monitor hormonal monitoring visit scheduling records (endocrinology follow-up every 3 months in infancy, every 3–4 months in childhood — appointment scheduling platform availability for the monitoring frequency required to detect breakthrough androgen excess before bone age advances), 17-OHP result records (morning fasting serum 17-OHP measured 2 hours after the first morning hydrocortisone dose — target 200–1000 ng/dL in children with classic CAH; 17-OHP >1500 ng/dL indicating undertreated ACTH excess; 17-OHP <100 ng/dL suggesting potential overtreatment), androstenedione and testosterone records (androstenedione and testosterone in the age-appropriate prepubertal range confirming adequate androgen suppression), urine pregnanetriol records (24-hour urine collection for pregnanetriol as an integrated 17-OHP metabolite measure, particularly useful when compliance with morning blood draw timing is unreliable), ACTH records (morning ACTH confirming absence of ACTH hyperstimulation at the monitored trough), and dose adjustment records (hydrocortisone dose in mg/m²/day — target 10–15 mg/m²/day with three daily doses, increasing by 10–15% increments for breakthrough androgen excess; fludrocortisone dose 0.05–0.2 mg/day with plasma renin activity in the mid-normal range as the target) at 1-minute intervals during clinical hours. Alert immediately — hormonal monitoring scheduling platform failures that prevent the 6-month follow-up appointment from being booked for a 4-year-old whose androstenedione was borderline elevated at the last visit leave a child with no confirmed appointment to check whether bone age advancement has progressed while inadequate hydrocortisone allows continued ACTH-driven androgen excess.
Multi-Disciplinary Endocrinology, Urology, and Gynecology Coordination
Monitor genital reconstructive surgery coordination records (surgical planning for virilized females with classic CAH: timing recommendation — clitoroplasty and vaginoplasty in infancy when performed versus delayed surgery with patient involvement, psychological assessment records, surgical technique documentation, post-operative follow-up scheduling), urology and gynecology follow-up scheduling records (annual urogynecologic examination from infancy, pubertal vaginal dilation protocol initiation at the appropriate developmental stage, annual Müllerian anatomy assessment by ultrasound), psychology coordination records (gender identity counseling, body image support, quality-of-life assessment, disclosure preparation for school and sports settings), reproductive endocrinology records (fertility counseling for adult females: ovulation induction, polycystic ovarian morphology monitoring, adrenal androgen suppression optimization for fertility), and testicular ultrasound records (annual testicular ultrasound for post-pubertal males for bilateral TART detection — echogenic intratesticular lesions at the rete testis, treatment by hydrocortisone dose intensification to suppress ACTH before surgical intervention if feasible) at 1-minute intervals during clinic hours. Alert on sustained platform failures — multi-disciplinary coordination portal failures delay the surgical planning conference communication between endocrinology, pediatric urology, and psychology for a 3-month-old girl with classic salt-wasting CAH and Prader stage 4 virilization whose family has been counseled about surgical options and is awaiting the multi-disciplinary recommendation.
Growth Monitoring, Bone Age, and Auxological Surveillance
Monitor height and weight measurement records (growth velocity calculation at every endocrinology visit — linear growth acceleration above the 97th percentile for height velocity indicating androgen excess; growth velocity below the 25th percentile for age indicating glucocorticoid overtreatment or GH deficiency from chronic cortisol excess), bone age radiograph records (left hand and wrist bone age by Greulich-Pyle atlas at diagnosis and annually thereafter — bone age advancement >2 standard deviations above chronological age indicating inadequate androgen suppression; bone age advancement causing early epiphyseal fusion and short final height prediction), GnRH analog records (in children with early epiphyseal fusion and gonadotropin-independent precocious puberty, GnRH analog use to slow bone age advancement while optimizing hormonal control), and final adult height records (target height calculation from mid-parental height, actual adult height comparison with target, GH therapy consideration for persistent height deficit in adults with childhood history of severe bone age advancement) at 1-minute intervals during clinical hours. Alert on failures — bone age radiograph ordering system unavailability prevents the annual bone age assessment for a 7-year-old female with classic CAH whose height velocity has been at the 90th percentile for the past year, delaying the detection of bone age advancement that would prompt urgent hormonal dose review.
Authentication and Clinical Identity
Monitor authentication at 1-minute intervals, 24/7. CAH management coordinates across pediatric endocrinology (hormonal monitoring and dose adjustment), newborn screening laboratory (17-OHP measurement and critical value reporting), emergency medicine (adrenal crisis management), pharmacy (hydrocortisone, fludrocortisone, sodium supplementation, emergency IM kit), urology and gynecology (genital reconstructive surgery), psychology (gender identity and body image counseling), reproductive endocrinology (adult fertility), and genetics (CYP21A2 molecular confirmation and family cascade testing) — authentication failures block every team member required to execute the adrenal crisis prevention, dose adjustment titration, and multi-disciplinary coordination that define CAH care.
SSL Certificates
Monitor SSL certificate expiry across all newborn screening LIS platforms, endocrinology scheduling portals, adrenal crisis emergency protocol systems, hormonal laboratory results platforms, multi-disciplinary coordination portals, and pharmacy dispensing systems. Certificate errors disrupt emergency protocol access and sick-day rule document availability — the most time-critical components of the CAH platform ecosystem.
HIPAA and Adrenal Disorder Patient Privacy Considerations
Congenital adrenal hyperplasia technology platforms handle highly sensitive PHI for a pediatric and adult population — including newborn bloodspot specimens with 17-OHP measurements, molecular genetic testing confirming heritable CYP21A2 mutations (autosomal recessive, with 25% recurrence risk for future pregnancies and 50% carrier probability for siblings — genetic implications extending to entire families), serial hormonal monitoring results documenting androgen levels and glucocorticoid dosing history, surgical records for genital reconstructive surgery with significant psychosocial sensitivity, gender identity and psychology counseling records, fertility records for adult females, and testicular ultrasound results for adult males.
The genetic information in CYP21A2 molecular analysis triggers GINA protections in addition to HIPAA Privacy and Security Rule requirements. The genital reconstructive surgery records and gender identity counseling documentation carry heightened sensitivity requiring access controls appropriate to the psychosocial stakes of inadvertent disclosure.
Alerting Strategy for Congenital Adrenal Hyperplasia Tech Platforms
Immediate 24/7 alerting for adrenal crisis emergency alert systems: Sick-day protocol portals, emergency IM hydrocortisone kit dispensing records, and emergency department clinical decision support. There is no acceptable window of unavailability for these platforms.
Immediate laboratory-hours alerting for newborn screening LIS: 17-OHP dried bloodspot analysis, gestational age correction, and critical value notification. These cannot fail during the daily specimen processing batches.
Immediate clinical-hours alerting for hormonal monitoring and scheduling platforms: Serial 17-OHP, androstenedione, testosterone, and dose adjustment scheduling for the narrow therapeutic window.
Immediate clinic-hours alerting for multi-disciplinary coordination portals: Genital reconstructive surgery planning, psychology coordination, and reproductive endocrinology for virilized females.
Immediate clinical-hours alerting for growth and bone age surveillance: Height velocity tracking and annual bone age radiograph scheduling.
Sustained-failure alert (10–15 minutes): Patient registry, CYP21A2 molecular genetic testing, and adult TART surveillance platforms.
30-day advance warning: SSL certificates across all domains, with priority for adrenal crisis emergency protocol portals.
Vigilmon's multi-region monitoring confirms CAH platform availability from the geographies where state newborn screening programs, pediatric endocrinology centers, and congenital adrenal hyperplasia centers of excellence concentrate.
Status Page for Congenital Adrenal Hyperplasia Care Team Communication
A real-time status page gives newborn screening laboratory directors processing daily 17-OHP batches, pediatric endocrinologists managing serial dose adjustment visits and sick-day protocol updates, emergency physicians accessing adrenal crisis management protocols, school nurses with CAH-specific individual health plans, pharmacists dispensing hydrocortisone and emergency IM kits, and pediatric urology and gynecology coordinators managing surgical planning conferences immediate platform visibility.
Include the status page URL in adrenal crisis emergency protocol documents distributed to families and emergency departments, newborn screening program critical value reporting backup procedures, and multi-disciplinary clinic coordination workflows.
Vigilmon Setup for Congenital Adrenal Hyperplasia Tech Platforms
A practical starting configuration:
| Monitor | Check Interval | Alert Channel | |---------|----------------|---------------| | Authentication | 1 min | Slack + PagerDuty (24/7) | | Adrenal crisis emergency protocol portal (sick-day rules, IM kit instructions) | 1 min | Slack + PagerDuty (24/7) | | Newborn screening LIS (17-OHP analysis and critical value notification) | 1 min | Slack + PagerDuty (lab hours) | | Confirmatory serum hormones (17-OHP, androstenedione, testosterone, electrolytes) | 1 min | Slack + PagerDuty (clinical hours) | | Endocrinology follow-up scheduling portal | 1 min | Slack + PagerDuty (clinic hours) | | Serial 17-OHP and androstenedione monitoring | 1 min | Slack + PagerDuty (clinical hours) | | Hydrocortisone dose adjustment documentation | 1 min | Slack + PagerDuty (clinical hours) | | Fludrocortisone dose and plasma renin tracking | 1 min | Slack + PagerDuty (clinical hours) | | Emergency hydrocortisone IM kit prescription and dispensing | 1 min | Slack + PagerDuty (24/7) | | Growth velocity monitoring (height/weight percentile) | 1 min | Slack + PagerDuty (clinical hours) | | Bone age radiograph ordering system | 1 min | Slack + PagerDuty (radiology hours) | | Multi-disciplinary coordination (endocrinology + urology/gynecology) | 1 min | Slack + PagerDuty (clinic hours) | | Psychology and gender identity counseling coordination | 2 min | Slack + PagerDuty (clinic hours) | | Testicular ultrasound (adult male TART surveillance) | 2 min | Slack (radiology hours) | | Patient registry and CYP21A2 molecular testing | 2 min | Slack (business hours) | | SSL: all domains | Daily | Email (30-day warning) |
Getting started:
- Create a free account at vigilmon.online
- Add authentication endpoints at 1-minute intervals with 24/7 alerting
- Configure adrenal crisis emergency protocol portal with 24/7 immediate alerting — this is the highest-priority platform in the CAH care ecosystem
- Add newborn screening LIS (17-OHP analysis) with immediate laboratory-hours alerting
- Configure confirmatory serum hormonal testing platforms with immediate clinical-hours alerting
- Add endocrinology follow-up scheduling portal with immediate clinic-hours alerting
- Configure serial 17-OHP and androstenedione monitoring platforms with immediate clinical-hours alerting
- Add hydrocortisone and fludrocortisone dose adjustment documentation with immediate clinical-hours alerting
- Configure emergency hydrocortisone IM kit prescription and pharmacy dispensing with 24/7 immediate alerting
- Add growth velocity monitoring (height/weight percentile plotting) with immediate clinical-hours alerting
- Configure bone age radiograph ordering system with immediate radiology-hours alerting
- Add multi-disciplinary coordination portal (endocrinology, urology/gynecology) with immediate clinic-hours alerting
- Configure psychology and gender identity counseling coordination platforms with sustained-failure alerting
- Add testicular ultrasound scheduling (adult male TART surveillance) with sustained-failure alerting
- Configure patient registry and CYP21A2 molecular genetic testing platforms with sustained-failure alerting
- Enable SSL certificate monitoring across all platforms, prioritizing adrenal crisis emergency protocol portals
- Add the status page URL to adrenal crisis emergency protocol documents distributed to families and emergency departments
Conclusion
Congenital adrenal hyperplasia technology platforms are embedded in clinical decisions where adrenal crisis emergency protocol portal availability at 2:00 AM when the parent of a 2-year-old with classic salt-wasting CAH accesses the patient portal to confirm the stress dosing instructions for a child with a temperature of 39.8°C, two episodes of vomiting, and a declining level of activity who cannot keep oral hydrocortisone down — when the parent needs to confirm that this is the scenario that requires the emergency intramuscular hydrocortisone injection and a call to emergency services before the child develops circulatory collapse from mineralocorticoid-deficient salt wasting and cortisol-deficient stress response — cannot be disrupted by patient portal failures that leave the parent without the sick-day protocol at the precise moment when the protocol determines whether the child spends the night in the pediatric intensive care unit or at home with an appropriately administered emergency injection; where newborn screening LIS availability during the daily 17-OHP analysis batch — when the neonatal specimen from a male infant born 6 days ago with classic salt-wasting CAH has a 17-OHP of 420 ng/mL bloodspot (six times the action level) that must trigger an immediate telephone call to the birth hospital to initiate same-day confirmatory testing and empirical hydrocortisone and fludrocortisone before the infant's sodium falls further from 132 mEq/L toward the range where adrenal crisis becomes inevitable — cannot be disrupted by LIS failures that delay the critical value notification by 24 hours while the infant's electrolytes continue to deteriorate; and where hormonal monitoring scheduling platform availability at the 3-month endocrinology follow-up — when the 17-OHP result of 2800 ng/dL in a 6-year-old with classic CAH indicates that the current hydrocortisone dose is inadequate and ACTH-driven androgen excess is advancing the bone age that will cost this child centimeters of final adult height if not corrected in the next 3 months — cannot be disrupted by scheduling system failures that prevent the dose adjustment and the 6-week recheck appointment from being booked before the next available slot is 4 months away. An adrenal crisis emergency portal unavailable when a family needs stress dosing instructions, a newborn screening LIS that cannot report a critical 17-OHP value before a salt-wasting neonate reaches circulatory collapse, a hormonal monitoring platform that cannot book the 6-week recheck after a breakthrough androgen excess result — these are not IT incidents. They are clinical disruptions in the management of a life-threatening endocrine disorder whose adrenal crisis mortality risk, androgen excess neurodevelopmental and auxological consequences, and multi-disciplinary care coordination complexity make emergency protocol 24/7 availability the single highest-priority platform requirement and serial hormonal monitoring the biochemical lifeline that protects every patient from the double jeopardy of undertreated virilization and overtreated glucocorticoid excess.
Uptime monitoring gives congenital adrenal hyperplasia tech teams the detection capability to identify failures within seconds, trigger immediate clinical downtime procedures, and demonstrate to newborn screening programs, pediatric endocrinology centers, emergency medicine departments, and compliance auditors that platform operational reliability matches the adrenal crisis prevention urgency, serial hormonal monitoring precision, and multi-disciplinary care coordination intensity of modern CAH management.
Start monitoring your congenital adrenal hyperplasia care tech platform for free at vigilmon.online — HTTP/HTTPS monitoring, multi-region consensus alerting, SSL certificate monitoring, automatic status page, Slack and webhook alerts. No agent required. No credit card.
Tags: #monitoring #congenital #adrenal #hyperplasia #CAH #CYP21A2 #21hydroxylase #17OHP #cortisol #aldosterone #fludrocortisone #hydrocortisone #adrenacrisis #sickday #stressdosing #androgen #virilization #newbornscreening #pediatric #endocrinology #HIPAA #healthtech #digitalhealth #uptime #sre